AI can improve drug combination design and personalized medicine

Must Read

Howdy Modi : Modi-Trump mark history in US-India relationship with great show at Houston

Houston, Sep 22:  Modi, delivering his speech at the historic event, talks about the development underwent over five years...

ECI announces dates of Maharashtra & Haryana elections; Single Phase Election on October 21; Result on 24th

Election Commission of India has announced the dates of much-awaited state elections. According to the Chief Election Commissioner, Sunil...

President Ram Nath Kovind appoints new governor for Kerala, Telangana, Himachal Pradesh and Maharashtra

President Ram Nath Kovind appointed new governors for Maharashtra, Kerala, Telangana, Rajasthan, and Himachal Pradesh on Sunday. Former Union Minister Kalraj...

A new auto-commentary that was published recently in the journal SLAS Technology talks about how an emerging area of artificial intelligence, especially the analysis of small systems-of-interest specific datasets, can now be used to significantly improve drug development and personalized medicine.

This new auto-commentary builds on a previous study that was recently published by the authors in Science Translational Medicine about an artificial intelligence (AI) platform, known as Quadratic Phenotypic Optimization Platform (QPOP), that has the potential to substantially improve combination therapy in bortezomib-resistant multiple myeloma to identify the best drug combinations for patients who suffer from individual multiple myeloma.

There’s now significant proof that complex diseases, such as cancer, often need effective drug combinations to achieve any significant therapeutic impact. As the drugs in these drug combination therapies become more and more specific to molecular targets, it makes designing effective drug combinations and also choosing the right drug combination for the right patient more and more difficult.

Artificial intelligence is now leading to a positive impact on drug development and personalized medicine. Along with the ability to efficiently analyze the small datasets that have the ability to focus on the specific disease of interest, QPOP and other small dataset-based AI platforms can intelligently design optimal drug combinations that are effectiver and based on real experimental data and not on the mechanistic assumptions or predictive modeling.

Additionally, due to the efficiency of the platform, QPOP can also used for the important patient samples to help optimize and personalize combination therapy.

The SLAS Technology auto-commentary, titled “Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine,” can be found here at


Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

Hamirpur Assembly bypolls underway in UP

Hamirpur (Uttar Pradesh), Sep 23 (IANS) Bye-election voting for Hamirpur Assembly segment seat began on Monday amid tight security.According...

Imran meets Khalilzad, Senator Lindsey Graham in NY

New York, Sep 23 (IANS) Pakistan Prime Minister Imran Khan, who is in New York to attend the 74th session of the UN General...

Lenovo K10 Plus with Triple rear camera, 4050 mAh battery available on Flipkart starting 30 Sep

Lenovo has recently launched budget-friendly Lenove K10 Plus on 22 September 2019. You can get the Lenovo K10 Plus starting at Rs 10,999 for...

Srishty Rode is simply gorgeous in Neon outfit in THESE latest photos

Srishty Rode is often our topic of discussion due to her strong fashion statements. In addition to having a successful TV career, Srishty is...

After Houston, PM Modi reaches New York

New York, Sep 23 (IANS) After his hugely successful Houston visit with the Howdy Modi event, Prime Minister Narendra Modi arrived in New York...
- Advertisement -

More Articles Like This